Security
Impel Pharmaceuticals Inc. Common Stock · IMPL
IMPLNASDAQCommon stockHistorical · closed Dec 15, 2023CIK 1445499Updated Nov 16, 2026
Name history
IMPEL PHARMACEUTICALS INC · through Feb 15, 2024IMPEL NEUROPHARMA INC · through Apr 14, 2022
IMPL price & chart
Historical security
This listing closed Dec 15, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 88,550,000Source | 97,912,000Source | 12,059,000Source |
| Property, Plant and Equipment, NetUSD | 3,863,000Source | 3,149,000Source | 3,700,000Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 60,654,000Source | 88,212,000Source | 7,095,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 7,444,000Source | 1,352,000Source | — |
| Inventory, NetUSD | 8,427,000Source | 2,824,000Source | 0Source |
| Assets, CurrentUSD | 79,809,000Source | 94,576,000Source | 8,172,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,284,000Source | 2,188,000Source | 1,077,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,132,000Source | — | — |
| Other Assets, NoncurrentUSD | 1,746,000Source | 187,000Source | 187,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 132,707,000Source | 45,404,000Source | 18,520,000Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 24,000Source | 23,000Source | — |
| Additional Paid in CapitalUSD | 276,929,000Source | 267,283,000Source | 4,762,000Source |
| Retained Earnings (Accumulated Deficit)USD | -321,110,000Source | -214,798,000Source | -138,262,000Source |
| Stockholders' Equity Attributable to ParentUSD | -44,157,000Source | 52,508,000Source | -133,500,000Source |
| Liabilities and EquityUSD | 88,550,000Source | 97,912,000Source | 12,059,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 22,163,000Source | 15,954,000Source | 10,526,000Source |
| Operating Lease, Liability, CurrentUSD | 1,541,000Source | — | — |
| Accounts Payable, CurrentUSD | 6,092,000Source | 6,367,000Source | 4,314,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,573,000Source | — | — |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | 12,242,000Source | 8,950,000Source | 3,173,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 0Source | 417,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 48,072,000Source | 29,450,000Source | 7,994,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -106,312,000Source | -76,536,000Source | -45,798,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 5,191,000Source | 3,130,000Source | 3,641,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | 6,092,000Source | 1,352,000Source | — |
| Increase (Decrease) in InventoriesUSD | 5,753,000Source | 3,023,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | -275,000Source | 1,999,000Source | 1,498,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -93,642,000Source | -66,364,000Source | -39,183,000Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,377,000Source | -408,000Source | -1,782,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,377,000Source | 408,000Source | 1,782,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 67,461,000Source | 147,889,000Source | 11,059,000Source |
| Repayments of Long-term DebtUSD | 32,853,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -27,558,000Source | 81,117,000Source | -29,906,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 60,654,000Source | 88,212,000Source | 7,095,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,589,000Source | 1,357,000Source | 134,000Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 5,191,000Source | 3,130,000Source | 3,641,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | -9,655,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -3,251,000Source | -1,993,000Source | — |
| General and Administrative ExpenseUSD | 77,885,000Source | 50,900,000Source | 17,036,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 2,000Source | 1,000Source |
| Inventory Write-downUSD | 138,000Source | 199,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -106,312,000Source | -76,536,000Source | -45,798,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -106,312,000Source | -76,665,000Source | -46,316,000Source |
| Operating ExpensesUSD | 89,341,000Source | 71,463,000Source | 45,334,000Source |
| Operating Lease, ExpenseUSD | 980,000Source | — | — |
| Other Nonoperating Income (Expense)USD | -9,293,000Source | -5,048,000Source | -463,000Source |
| Proceeds from Issuance of Common StockUSD | 4,253,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 203,000Source | 796,000Source | 879,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Total RevenueUSD | 12,652,000Source | 668,000Source | — |
| Cost of Goods and Services Sold | — | — | — |
| Operating Income (Loss)USD | -83,184,000Source | -71,486,000Source | -45,334,000Source |
| Other Nonoperating Income (Expense)USD | -9,293,000Source | -5,048,000Source | -463,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -106,312,000Source | -76,534,000Source | -45,797,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 2,000Source | 1,000Source |
| Net Income (Loss) Attributable to ParentUSD | -106,312,000Source | -76,536,000Source | -45,798,000Source |
| Earnings Per Share, BasicUSD per share | -4.53Source | — | — |
| Earnings Per Share, DilutedUSD per share | -4.53Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 23,445,096Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 23,445,096Source | — | — |
| Additional Financial Items | |||
| Current Income Tax Expense (Benefit)USD | 0Source | 2,000Source | 1,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,201,000Source | 1,088,000Source | 1,077,000Source |
| General and Administrative ExpenseUSD | 77,885,000Source | 50,900,000Source | 17,036,000Source |
| Gross ProfitUSD | 6,157,000Source | 23,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -106,279,000Source | -76,512,000Source | -45,801,000Source |
| Interest Income (Expense), NetUSD | -13,835,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -106,312,000Source | -76,665,000Source | -46,316,000Source |
| Operating ExpensesUSD | 89,341,000Source | 71,463,000Source | 45,334,000Source |
| Operating Lease, ExpenseUSD | 980,000Source | — | — |
| Research and Development ExpenseUSD | 11,456,000Source | 20,563,000Source | 28,298,000Source |